Medical Science Liaison, Rare Disease
by AstraZeneca in Pharmaceuticals
The Medical Science Liaison (MSL), Rare Disease at AstraZeneca will engage with Key External Experts (KEEs), primarily in haematology and nephrology, to facilitate scientific exchange and support the companyâs strategic goals in these therapeutic areas. The role is crucial in shaping the medical strategy by generating insights, delivering non-promotional clinical data, and fostering strong scientific partnerships with major hospitals, healthcare institutions, and non-traditional stakeholders. This position involves acting as a scientific expert internally and externally, delivering education, supporting evidence generation, responding to unsolicited information requests, and enhancing the understanding and accessibility of AstraZenecaâs rare disease treatments.